Dexrazoxane Preserves Cardiac Function in Pediatric Leukemia
Beneficial for patients with AML receiving anthracyclines, with no impact on event-free, overall survival
For Those With Heart Failure, ACE2 Concentrations Up in Men
Use of ACE inhibitors, ARBs not tied to higher plasma ACE2 concentrations in those with heart failure
Pediatric Vaccine Ordering Has Decreased During COVID-19
Decrease seen in VFC-funded APIC-recommended childhood vaccines after national emergency declaration
Crude Link ID’d for Vitamin D Levels, COVID-19 Cases, Death
Vitamin D levels severely low in aging population, the most vulnerable population to COVID-19
Anakinra May Reduce Systemic Inflammation in COVID-19
At 21 days, survival was 90 percent in anakinra group versus 56 percent in standard treatment group
Triple Antiviral Therapy Promising for Mild-to-Moderate COVID-19
Duration of viral shedding shorter with combination of lopinavir-ritonavir, ribavarin, interferon beta-1b
Residual Shunt After PFO Closure Linked to Higher Risk for Stroke
Risk for recurrent stroke, transient ischemic attack increased with presence of residual shunt
Hydroxychloroquine Has No Impact on Outcomes in COVID-19
No link seen between use of the drug and risk for composite end point of intubation or death
ACE Inhibitor/ARB Use Not Tied to COVID-19 Test Positivity
No significant association identified in overlap propensity score weighting analysis
Risk for SARS-CoV-2 Lower for Prostate Cancer Patients on ADT
Risk reduced fourfold with androgen-deprivation therapy versus other treatment for prostate cancer
